ResearcherJohns Hopkins UniversityActive in the last 2 years

Hassan Sinan

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0000-4402-3499; OpenAlex author ID A5033859760. Sources: OpenAlex.

Their work

Papers: 3
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 26

Papers, trials and grants by year

2025: 1 paper · 2026: 2 papers

Papers 3

Association of obstructive sleep apnea with pancreatic cancer in high-risk patients under surveillance in CAPS and PCYST cohorts. Co-author DOI 10.1016/j.pan.2026.10.013 ↗
First-in-human testing of a mutant KRAS vaccine for pancreatic cancer interception in high-risk cohorts. Co-author DOI 10.1158/2159-8290.cd-25-2245 ↗
Cancer Susceptibility Gene Testing in Patients With Pancreatic Ductal Adenocarcinoma: Implementation in a Cancer Center Oncology Clinic. Co-author DOI 10.1200/po-24-00494 ↗

Closest collaborators

The 25 strongest of 26 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Michael Goggins · 3 shared papers, 2025–2026 · strength 0.67
- Paper Association of obstructive sleep apnea with pancreatic cancer in high-risk patients under surveillance in CAPS and PCYS… DOI 10.1016/j.pan.2026.10.013 ↗
- Paper Cancer Susceptibility Gene Testing in Patients With Pancreatic Ductal Adenocarcinoma: Implementation in a Cancer Center… DOI 10.1200/po-24-00494 ↗
- Paper First-in-human testing of a mutant KRAS vaccine for pancreatic cancer interception in high-risk cohorts. DOI 10.1158/2159-8290.cd-25-2245 ↗
Neeha Zaidi · 2 shared papers, 2025–2026 · strength 0.42
- Paper Cancer Susceptibility Gene Testing in Patients With Pancreatic Ductal Adenocarcinoma: Implementation in a Cancer Center… DOI 10.1200/po-24-00494 ↗
- Paper First-in-human testing of a mutant KRAS vaccine for pancreatic cancer interception in high-risk cohorts. DOI 10.1158/2159-8290.cd-25-2245 ↗
Nilofer Saba Azad · 2 shared papers, 2025–2026 · strength 0.42
- Paper Cancer Susceptibility Gene Testing in Patients With Pancreatic Ductal Adenocarcinoma: Implementation in a Cancer Center… DOI 10.1200/po-24-00494 ↗
- Paper First-in-human testing of a mutant KRAS vaccine for pancreatic cancer interception in high-risk cohorts. DOI 10.1158/2159-8290.cd-25-2245 ↗
Daniel A. Laheru · 2 shared papers, 2025–2026 · strength 0.42
- Paper Cancer Susceptibility Gene Testing in Patients With Pancreatic Ductal Adenocarcinoma: Implementation in a Cancer Center… DOI 10.1200/po-24-00494 ↗
- Paper First-in-human testing of a mutant KRAS vaccine for pancreatic cancer interception in high-risk cohorts. DOI 10.1158/2159-8290.cd-25-2245 ↗
Marcia Irene Canto · 1 shared paper, 2026 · strength 0.26
- Paper Association of obstructive sleep apnea with pancreatic cancer in high-risk patients under surveillance in CAPS and PCYS… DOI 10.1016/j.pan.2026.10.013 ↗
Amanda L. Blackford · 1 shared paper, 2026 · strength 0.26
- Paper Association of obstructive sleep apnea with pancreatic cancer in high-risk patients under surveillance in CAPS and PCYS… DOI 10.1016/j.pan.2026.10.013 ↗
Eun Ji Shin · 1 shared paper, 2026 · strength 0.26
- Paper Association of obstructive sleep apnea with pancreatic cancer in high-risk patients under surveillance in CAPS and PCYS… DOI 10.1016/j.pan.2026.10.013 ↗
Elham Afghani · 1 shared paper, 2026 · strength 0.26
- Paper Association of obstructive sleep apnea with pancreatic cancer in high-risk patients under surveillance in CAPS and PCYS… DOI 10.1016/j.pan.2026.10.013 ↗
Jin Peng He · 1 shared paper, 2025 · strength 0.21
- Paper Cancer Susceptibility Gene Testing in Patients With Pancreatic Ductal Adenocarcinoma: Implementation in a Cancer Center… DOI 10.1200/po-24-00494 ↗
Richard A. Burkhart · 1 shared paper, 2025 · strength 0.21
- Paper Cancer Susceptibility Gene Testing in Patients With Pancreatic Ductal Adenocarcinoma: Implementation in a Cancer Center… DOI 10.1200/po-24-00494 ↗
Lei Zheng · 1 shared paper, 2025 · strength 0.21
- Paper Cancer Susceptibility Gene Testing in Patients With Pancreatic Ductal Adenocarcinoma: Implementation in a Cancer Center… DOI 10.1200/po-24-00494 ↗
Michael Jon Pishvaian · 1 shared paper, 2025 · strength 0.21
- Paper Cancer Susceptibility Gene Testing in Patients With Pancreatic Ductal Adenocarcinoma: Implementation in a Cancer Center… DOI 10.1200/po-24-00494 ↗
Dimitrios N. Sidiropoulos · 1 shared paper, 2026 · strength 0.21
- Paper First-in-human testing of a mutant KRAS vaccine for pancreatic cancer interception in high-risk cohorts. DOI 10.1158/2159-8290.cd-25-2245 ↗
Hao Wang · 1 shared paper, 2026 · strength 0.21
- Paper First-in-human testing of a mutant KRAS vaccine for pancreatic cancer interception in high-risk cohorts. DOI 10.1158/2159-8290.cd-25-2245 ↗
Saurav Daniel Haldar · 1 shared paper, 2026 · strength 0.21
- Paper First-in-human testing of a mutant KRAS vaccine for pancreatic cancer interception in high-risk cohorts. DOI 10.1158/2159-8290.cd-25-2245 ↗
Marina Baretti · 1 shared paper, 2026 · strength 0.21
- Paper First-in-human testing of a mutant KRAS vaccine for pancreatic cancer interception in high-risk cohorts. DOI 10.1158/2159-8290.cd-25-2245 ↗
Takeichi Yoshida · 1 shared paper, 2026 · strength 0.21
- Paper First-in-human testing of a mutant KRAS vaccine for pancreatic cancer interception in high-risk cohorts. DOI 10.1158/2159-8290.cd-25-2245 ↗
Luciane Tsukamoto Kagohara · 1 shared paper, 2026 · strength 0.21
- Paper First-in-human testing of a mutant KRAS vaccine for pancreatic cancer interception in high-risk cohorts. DOI 10.1158/2159-8290.cd-25-2245 ↗
Mark M. Yarchoan · 1 shared paper, 2026 · strength 0.21
- Paper First-in-human testing of a mutant KRAS vaccine for pancreatic cancer interception in high-risk cohorts. DOI 10.1158/2159-8290.cd-25-2245 ↗
Matthew Z. Guo · 1 shared paper, 2026 · strength 0.21
- Paper First-in-human testing of a mutant KRAS vaccine for pancreatic cancer interception in high-risk cohorts. DOI 10.1158/2159-8290.cd-25-2245 ↗
Elizabeth Abou Diwan · 1 shared paper, 2026 · strength 0.21
- Paper First-in-human testing of a mutant KRAS vaccine for pancreatic cancer interception in high-risk cohorts. DOI 10.1158/2159-8290.cd-25-2245 ↗
Elizabeth M. Jaffee · 1 shared paper, 2026 · strength 0.21
- Paper First-in-human testing of a mutant KRAS vaccine for pancreatic cancer interception in high-risk cohorts. DOI 10.1158/2159-8290.cd-25-2245 ↗
Won Jin Ho · 1 shared paper, 2026 · strength 0.21
- Paper First-in-human testing of a mutant KRAS vaccine for pancreatic cancer interception in high-risk cohorts. DOI 10.1158/2159-8290.cd-25-2245 ↗
Katherine M. Bever · 1 shared paper, 2026 · strength 0.21
- Paper First-in-human testing of a mutant KRAS vaccine for pancreatic cancer interception in high-risk cohorts. DOI 10.1158/2159-8290.cd-25-2245 ↗
Amanda L. Huff · 1 shared paper, 2026 · strength 0.21
- Paper First-in-human testing of a mutant KRAS vaccine for pancreatic cancer interception in high-risk cohorts. DOI 10.1158/2159-8290.cd-25-2245 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.